Abstract
To examine the efficacy and safety of tolvaptan in acute decompensated heart failure patients with reduced left ventricular systolic function. A total of 145 hospitalized acute decompensated heart failure patients were randomly assigned to either a tolvaptan(n=79) or a control group(n=66) which
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have